EUVIMEDOpdag EUVIMED
Video/AudioMultizentrische Studie

Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations

Adriana Plesa, Florent Dumezy, Stéphanie Mathis, Isabelle Arnoux, Veronique Saada, Valerie Bardet, Iole Oster, Bouchra Badaoui, Elsa Bera, Edouard Bonneville, Boutheina Bouslama, Nicolas Chapuis and 45 more

Journal of Visualized Experiments · 2026

DOI: 10.3791/71304 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Adriana Plesa and 56 co-authors. Institution: Laboratory of Hematology and Flow cytometry, Lyon-Sud Hospital; CRCL INSERM 1052/CNRS 5286, University of Lyon; adriana.plesa@chu-lyon.fr. Major MEDLINE topics: Flow Cytometry, Leukemia, Myeloid, Acute, Neoplastic Stem Cells. 34 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Measurable residual disease (MRD) follow-up is recommended for treatment response evaluation in acute myeloid leukemia (AML) clinical trials according to ELN 2025 guidelines. The aim of this study was to implement a standardized follow-up of patients using a harmonized MRD flow approach across 30 French hematology laboratories participating in AML clinical trials. To obtain comparable results, the network established recommendations from wet-lab procedures to clinical reports. We designed a 3-tube panel with mandatory 8-color common markers per tube, according to ELN recommendations, to identify leukemia-associated immunophenotype/different-from-normal (LAIP/DfN) patterns in bulk cells and leukemic stem cell (LSC)-enriched populations in the CD34+CD38- fraction. A backbone of CD34/CD38/CD45/CD117 was used, completed by lineage markers for the first tube, LSC-associated markers for the second tube, and monocytic and differentiation markers for the third tube. This panel can be used in 8-, 10-, and 12-color formats and implemented on multiple conventional flow cytometer platforms. We propose flow cytometer settings adapted to each platform. Harmonization of sensitivity between the four platforms was performed using 8-peak rainbow beads. Immunostaining was performed after bulk lysis. To detect bias between platforms, the staining index was tested using fresh healthy bone marrow samples in parallel on the four platforms. Regular bone marrow quality-control samples were shared among laboratories for wet external quality assessment (EQA) to verify all steps of the protocol. Finally, standardization of the data analysis strategy obtained in the centers was evaluated using dry EQA by sharing MRD FCS data files. The feasibility of this multicenter approach requires harmonization of instrument sensitivity and sample preparation, as well as training and systematic education of analytical operators.

Subjects

MeSH terms (MEDLINE)

Flow CytometryLeukemia, Myeloid, AcuteNeoplastic Stem CellsHumansNeoplasm, ResidualADP-ribosyl Cyclase 1Antigens, CD34Immunophenotyping

Substances

ADP-ribosyl Cyclase 1Antigens, CD34

Authors and institutions

  • Laboratory of Hematology and Flow cytometry, Lyon-Sud Hospital; CRCL INSERM 1052/CNRS 5286, University of Lyon; adriana.plesa@chu-lyon.fr.
  • Laboratory of Hematology and Flow cytometry, CHU-Lille.
  • Laboratory of Hematology and Flow cytometry, Saint Louis Hospital.
  • Laboratory of Hematology and Flow cytometry, APHM-Marseille.
  • Laboratory of Hematology and Flow cytometry, IGR.
  • Laboratory of Hematology and Flow cytometry, Ambroise Pare University Hospital.

Cite

APA

Plesa, A., Dumezy, F., Mathis, S., Arnoux, I., Saada, V., Bardet, V., Oster, I., Badaoui, B., Bera, E., Bonneville, E., Bouslama, B., Chapuis, N., Chauvel, C., Cornet, E., Dannus, L. T., Debord, C., Feger, F., Feuillard, J., Fournet, T., …, & Roumier, C. (2026). Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations. Journal of Visualized Experiments. https://doi.org/10.3791/71304

Vancouver

Plesa A, Dumezy F, Mathis S, Arnoux I, Saada V, Bardet V, et al. Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations. Journal of Visualized Experiments. 2026. doi:10.3791/71304

BibTeX
@article{Plesa2026,
  author = {Plesa, Adriana and Dumezy, Florent and Mathis, Stéphanie and Arnoux, Isabelle and Saada, Veronique and Bardet, Valerie and Oster, Iole and Badaoui, Bouchra and Bera, Elsa and Bonneville, Edouard and Bouslama, Boutheina and Chapuis, Nicolas and Chauvel, Clementine and Cornet, Edouard and Dannus, Louis Thomas and Debord, Camille and Feger, Fréderic and Feuillard, Jean and Fournet, Thomas and Garnache, Francine and Geneviève, Franck and Gerard, Delphine and Monteiro, Valerie Goncalves and Guy, Julien and Harrivel, Veronique and Hemar, Claire and Jadeau, Cassandra and Mayeur-Rousse, Caroline and Lapillonne, Hélène and Latger-Cannard, Veronique and Garff-Tavernier, Magali Le and Lemaire, Pierre and Letestu, Remi and Lhoumeau, Anne Catherine and Manzoni, Delphine and Mimoun, Aguirre and Nivaggioni, Vanessa and Osman, Jennifer and Raggueneau, Victoria and Rambaud, Hubert and Raskovalova, Tatiana and Roggy, Anne and Roussel, Mikael and Sciortino, Didier and Soenen, Valerie and Vergez, François and Masson, Richard Veyrat and Vial, Jean Philippe and Vogrig, Manon and Wagner-Ballon, Orianne and Zhu, Jaja and Celli-Lebras, Karine and Itzykson, Raphaël and Recher, Christian and Dombret, Hervé and Preudhomme, Claude and Roumier, Christophe},
  title = {Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71304}
}
Start for free →